BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 17, 2021

Total Value ($000): $1,880,955 (100.0% shares, 0.0% debt)

Holdings (8)

STAA STAAR SURGICAL CO 53.5%

Value ($000) $1,006,043 Shares 9,544,091 Est. Cost $8.21 Unrealized +1119.5%

MNST MONSTER BEVERAGE CORP NEW 22.6%

Value ($000) $424,159 Shares 4,656,488 Est. Cost $22.71 Unrealized +97.3%

IWM ISHARES TR 8.1%

Value ($000) $152,449 Shares 690,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 5.8%

Value ($000) $108,248 Shares 760,062 Est. Cost $27.50 Unrealized +466.9%

— ONCOCYTE CORP 4.6%

Value ($000) $87,070 Shares 16,776,484 Est. Cost $3.38 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS IN 4.2%

Value ($000) $79,913 Shares 34,005,379 Est. Cost $1.03 Unrealized +133.0%

MNST MONSTER BEVERAGE CORP NEW 1.0%

Value ($000) $18,218 Shares 200,000 Est. Cost $22.71 Unrealized +97.3%

— AGEX THERAPEUTICS INC 0.3%

Value ($000) $4,855 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	9,544,091	$1,006,043	53.5%	$8.21	+1119.5%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$424,159	22.6%	$22.71	+97.3%	COM	61174X109
IWM	ISHARES TR	690,000	$152,449	8.1%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$108,248	5.8%	$27.50	+466.9%	COM	05464C101
—	ONCOCYTE CORP	16,776,484	$87,070	4.6%	$3.38	—	COM	68235C107
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$79,913	4.2%	$1.03	+133.0%	COM	53566P109
MNST	MONSTER BEVERAGE CORP NEW	200,000	$18,218	1.0%	$22.71	+97.3%	Put	61174X109
—	AGEX THERAPEUTICS INC	2,997,156	$4,855	0.3%	$2.99	—	COM	00848H108